Friday 02 May 2025
Internal Reference Number: FOI_8513
Date Request Received: 12/03/2025 00:00:00
Date Request Replied To: 01/04/2025 00:00:00
This response was sent via: By Email
Request Summary: Request on HAE and IG
Request Category: Researcher
| Question Number 1: I have a freedom of information request I would appreciate your assistance with, can you please answer the following In the past 3 months, how many patients have received the following treatments (for any disease): • Berinert (Human C1-esterase inhibitor) • Cinryze (Human C1-esterase inhibitor) • Firazyr (Icatibant) • Icatibant - any brand except Firazyr • Orladeyo (Berotralstat) • Ruconest (Recombinant human C1-esterase inhibitor) • Takhzyro (Lanadelumab) • Garadacimab (Andembry) | |
| Answer To Question 1: Zero for all products | |
| Question Number 2: Q2. In the past 3 months how many patients have received the following immunoglobulin treatments (for any disease): • Cutaquig • Cuvitru • Gammagard • Gammanorm • Hizentra • Hyqvia • Intratect • Iqymune • Kiovig • Privigen • Octagam • Panzyga • Subgam • Any other normal immunoglobulin | |
| Answer To Question 2: Privigen 29 patients Iqymune 7 patients Intratect 10 patients Octagam <5 patients Any other normal immunoglobulin (Gamunex) <5 patients 0 patients received any of the other products listed | |
| To return to the list of all the FOI requests please click here |
Our staff at Salisbury District Hospital have long been well regarded for the quality of care and treatment they provide for our patients and for their innovation, commitment and professionalism. This has been recognised in a wide range of achievements and it is reflected in our award of NHS Foundation Trust status. This is afforded to hospitals that provide the highest standards of care.
